openPR Logo
Press release

Cardiac Biomarkers Market 2020-2026: Market Share, Applications, Growth Trends and Forecast Report

09-02-2020 05:35 PM CET | Health & Medicine

Press release from: Fortune Business Insights Private Limited

Cardiac Biomarkers Market

Cardiac Biomarkers Market

The acute coronary syndrome sub-segment under application segment is projected to dominate the global “cardiac biomarkers market during the forecast period. It is likely to occur due to a rise in the investment by various health institutes in biomarker testing for early detection of the disease. This information is given in an upcoming report by Fortune Business Insights, titled, “Cardiac Biomarkers Market Size”, Share and Global Trend By Type (Troponin, Creatine kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), and N-terminal pro b-type natriuretic peptide (NT-proBNP), Myoglobin), By Application (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure), By End User (Hospitals, Diagnostic Centers, Homecare Settings) and Geography Forecast till 2026.

For More Information in the Analysis of Report: https://www.fortunebusinessinsights.com/industry-reports/cardiac-biomarkers-market-101233

Persistent Technological Advancement for Developing Biomarkers to Drive Global Market
Fortune Business Insights states in the report that the main reason behind the ever-increasing demand for cardiac biomarkers is because of the rising incidence of cardiovascular diseases, which, in turn, is increasing the demand for early detection of the diseases. Moreover, innovative product launches by prominent market players and increasing fast track approvals are expected to drive the global cardiac biomarkers market growth in the forecast period. Also, a rise in the technological advancements in the field of cardiac biomarkers and increasing demand for point of care testing kits are likely to contribute to the global market growth in the upcoming years.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cardiac-biomarkers-market-101233

Key Companies and Manufacturers Covered:
• Thermo Fisher Scientific
• Abbott
• Becton
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd.
• Randox Laboratories Ltd.
• Beckman Coulter, Inc.
• Dickinson and Company
• Dickinson and Company
• bioMérieux SA
• Other key market players

Siemens and Roche Receive FDA Clearance for Their Products to Aid in Early Detection of Heart Attack

Siemens Healthineers, a prominent healthcare company, based in Germany, announced in July 2018 that it bagged FDA approval for high-sensitivity troponin I assays (TnIH). They would be used on the company’s Advia Centaur XP/XPT as well as Atellica IM immunoassay analyzers. It would further support in the early diagnosis of heart attacks or myocardial infarctions. Siemens declared that the two TnIH assays possess high sensitivity. Therefore, it would aid in detecting minute changes in troponin levels in patients as well as finding lower levels of troponin. The testing has to be conducted repeatedly to achieve the desired results. That is why doctors and clinicians would gain more confidence in the results and immediately begin treatment of the same.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/cardiac-biomarkers-market-101233

Cardiac Biomarkers Market Segmentation:

By Type
• Troponin
• Creatine kinase-MB (CK-MB)
• B-type Natriuretic Peptide (BNP), and N-terminal pro b-type natriuretic peptide (NT-proBNP)
• Myoglobin
• Others
By Application
• Acute Coronary Syndrome
• Myocardial Infarction
• Congestive Heart Failure
• Others
By End User
• Hospitals
• Diagnostic Centers
• Homecare Settings
• Others
By Geography
• North America (USA and Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
• Latin America (Brazil, Mexico and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Order Full Report: https://www.fortunebusinessinsights.com/checkout-page/101233

Our proven methodologies and systematic analysis help in making confident business and strategic decisions.
A market study that conducts at Fortune Business Insights can save significant cost and time, and can help prevent making costly mistakes.

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Biomarkers Market 2020-2026: Market Share, Applications, Growth Trends and Forecast Report here

News-ID: 2126684 • Views: 191

More Releases from Fortune Business Insights Private Limited

Biobanking Market 2020: Recent Industry Trends, Top Manufacturers, Market Growth …
The global “biobanking market Share” is set to gain traction from the rising integration of innovative technologies in the pre-existing systems. Besides, the introduction to virtual biobanking is set to revolutionize the system by enabling researchers to conduct their studies smoothly, as well as by lowering the time constraints. This information is published by Fortune Business Insights™ in a recent study, titled, “Biobanking Market Size, Share & Industry Analysis, By
Bone Void Fillers Market 2020 | Global Industry Size, Regional Analysis, Explosi …
The global bone void fillers market will derive growth from recent product advancements. According to a report by Fortune Business Insights, titled “Bone Void Fillers Market Growth”, Share and Global Trend By Material Type (Demineralized Bone Matrix, Collagen Matrix, Calcium Sulphate, Hydroxyapatite, Tri-Calcium Phosphate, Others), By Forms (Gel, Granules, Putty, Paste, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Geography Forecast till 2026,” the market will
Medical Mask Market 2020 Global Size, Share, Growth Factor and Forecast 2026
The global “medical masks market size” is projected to reach USD 4.11 billion by the end of 2027. The increasing incidence of coronavirus across the world will have a huge impact on market growth. According to a report published by Fortune business Insights, titled “Medical Mask Market Size, Share & Industry Analysis, By Type (Surgical Mask, Respirators, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and
Ventilator Market 2020 Global Industry Share, Size, Growth Analysis and Forecast …
The global “ventilators market size” is estimated to gain momentum on account of the increasing number of ICU admissions that require mechanical ventilation. This is further attributed to the growing prevalence of chronic diseases that requires critical care equipment such as incubators, ventilator, and other devices. A recent report by Fortune Business Insights, titled, “Ventilator Market Size, Share & Covid-19 Impact Analysis, By Type (Adult, and Pediatric & Neonatal), By

All 5 Releases


More Releases for Biomarkers

Biomarkers Market Fragmented by 2025
Global Biomarkers Market: Snapshot The global biomarkers market is witnessing a tremendous rise in its valuation, thanks to the increase in diagnostic applications of biomarkers. The augmenting investments for research and development activities in the pharma and biotech companies, rising number of CROs, and the low cost associated with the clinical trials in emerging economies are also boosting this market. Going forward, the high prevalence rate of cancer and novel initiatives for
Cancer Biomarkers Market: Regional Overview
Cancer is the second-leading cause of death worldwide (World Health Organization). There were around 14 million new cases of cancer reported across the globe in 2012 and the incidence rate is expected to increase by around 70% by 2030 (WHO). The most common cancer types are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer. Cancer therapies are expensive and the cost rises with increase in complexity or stage
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Biomarkers Market : Analysis & Trends 2023
Global Biomarkers Market A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions
Global Vocal Biomarkers Market
The Global Vocal Biomarkers Market is estimated to be valued at US$ 6.4 million by 2017 and is projected to expand at an astounding CAGR of 65.7% from 2017 to 2028, as analyzed by Coherent Market Insights. Vocal biomarkers enabling early diagnosis and being a non-invasive procedure are analyzed to be major factor fueling uptake of this disruptive technology over the forecast period (2017–2028). Mental and physical conditions such as anxiety
Biomarkers Summit
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out